MGI Tech Past Earnings Performance
Past criteria checks 0/6
MGI Tech has been growing earnings at an average annual rate of 3%, while the Life Sciences industry saw earnings growing at 21.9% annually. Revenues have been declining at an average rate of 22.2% per year.
Key information
3.0%
Earnings growth rate
20.3%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | -22.2% |
| Return on equity | -7.9% |
| Net Margin | -23.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Is MGI Tech Co., Ltd. (SHSE:688114) Trading At A 26% Discount?
Jun 03
Newsflash: MGI Tech Co., Ltd. (SHSE:688114) Analysts Have Been Trimming Their Revenue Forecasts
Apr 29Is MGI Tech (SHSE:688114) Using Debt In A Risky Way?
Mar 28Investor Optimism Abounds MGI Tech Co., Ltd. (SHSE:688114) But Growth Is Lacking
Feb 29Revenue & Expenses Breakdown
How MGI Tech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,823 | -659 | 1,475 | 894 |
| 31 Dec 23 | 2,911 | -607 | 1,414 | 910 |
| 30 Sep 23 | 3,145 | -193 | 1,257 | 931 |
| 30 Jun 23 | 3,313 | 1,585 | 1,247 | 897 |
| 31 Mar 23 | 3,630 | 1,534 | 1,279 | 877 |
| 31 Dec 22 | 4,231 | 2,026 | 1,246 | 814 |
| 30 Sep 22 | 4,372 | 2,046 | 1,349 | 677 |
| 30 Jun 22 | 4,331 | 402 | 1,281 | 550 |
| 31 Mar 22 | 4,169 | 613 | 1,193 | 623 |
| 31 Dec 21 | 3,929 | 484 | 1,222 | 608 |
| 30 Sep 21 | 3,887 | 555 | 1,232 | 670 |
| 31 Dec 20 | 2,780 | 261 | 1,063 | 700 |
| 31 Dec 19 | 1,091 | -244 | 304 | 343 |
| 31 Dec 18 | 1,097 | 125 | 225 | 254 |
| 31 Dec 17 | 802 | -42 | 196 | 245 |
Quality Earnings: 688114 is currently unprofitable.
Growing Profit Margin: 688114 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688114 is unprofitable, but has reduced losses over the past 5 years at a rate of 3% per year.
Accelerating Growth: Unable to compare 688114's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 688114 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (0.7%).
Return on Equity
High ROE: 688114 has a negative Return on Equity (-7.91%), as it is currently unprofitable.